drugset / Trial / NCT00285701
Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Patients referred for colon inspection (colonoscopy) due to suspicion of colon polyps/cancer will receive local administration of hexaminolevulinate (HAL) prior to colon inspection. Blue light illumination will induce red fluorescence of polyps and tumours, improving detection of the polyps and tumors. Different HAL doses will be tested to find the optimal image conditions. Tolerability measurements will be performed to ensure patient safety.
Timeline
- Start
- 2006-07
- Primary completion
- 2007-11
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hexaminolevulinate | Small molecule | — | Other |